24 Sep 2020 11:00 AM online

The new Sievers Eclipse Bacterial Endotoxins Testing (BET) Platform combines ground-breaking technology and ease-of-use to automate endotoxin assay setup without altering reaction biochemistry or compliance. It reduces usage of Limulus Amoebocyte Lysate (LAL) reagent by up to 90 percent and increases the speed and ease with which the assay can be started. With Eclipse, compliant 21-sample assays can be set up in as little as nine minutes with minimal analyst training, leading to substantial efficiency gains and reduction of human errors.

 

Join this webinar to get answers to the following questions:  how does the Eclipse technology work? Why is so little LAL required? How do analytical results on the Eclipse compare to other platforms? What about validation and data integrity?